tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Income Statement

Compare
540 Followers

Neurogene Income Statement

Last quarter (Q3 2024), Neurogene's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Neurogene's net income was $-20.22M. See Neurogene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.26M$ -3.20M$ -2.28M$ -1.82M$ -340.00K
Operating Expenses
$ 55.58M$ 56.52M$ 50.53M$ 39.73M$ 24.10M
Depreciation and Amortization
$ 3.30M$ 3.20M$ 2.28M$ 1.82M$ 340.00K
EBITDA
$ -52.29M$ -51.99M$ -49.59M$ -31.46M$ -69.10M
Operating Income
$ -55.58M$ -56.52M$ -50.53M$ -41.55M$ -24.44M
Other Income/Expenses
$ 19.27M$ 1.33M$ 17.00K$ 8.28M$ -45.00M
Pretax Income
$ -36.32M$ -55.19M$ -50.52M$ -33.28M$ -69.44M
Net Income
$ -36.32M$ -55.19M$ -50.52M$ -33.28M$ -69.44M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.83$ -4.30$ -0.92$ -0.64$ -2.57
Diluted EPS
$ -2.83$ -4.30$ -0.92$ -0.64$ -2.57
Weighted Average Shares Outstanding
12.82M 12.82M 55.04M 51.83M 27.03M
Weighted Average Shares Outstanding (Diluted)
12.82M 12.82M 55.04M 51.83M 27.03M
Currency in USD

Neurogene Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis